Kevin Church

Kevin Church, Ph.D., has served in various roles at Athira since 2016, including Research Scientist, Director of Discovery, now as Vice President of Discovery. Dr. Church has research experience in diverse fields of study including neurodegenerative diseases, wound healing, and cancer.

Dr. Church earned his Ph.D. in molecular biosciences from Washington State University in 2016, and prior to that earned his B.S. in microbiology from the University of Idaho in 2006. While in graduate school, Dr. Church was recognized for excellence in his graduate teaching assistantships. Dr. Church’s graduate work primarily focused on the development of novel therapeutics for the treatment of pancreatic cancer, but also included research relating to the treatment of diabetic ulcers and neurodegenerative diseases such as Parkinson’s disease dementia and Alzheimer’s disease.